Sjællands Universitetshospital

Medicin og biovidenskab

1. Denmark 100%
2. Hidradenitis Suppurativa 88%
3. Cohort Studies 63%
4. Randomized Controlled Trials 55%
5. Neoplasms 51%
6. Systematic Reviews 50%
7. Therapeutics 46%
8. Mortality 40%
9. Population 40%
10. Registries 37%
11. Confidence Intervals 34%
12. Quality of Life 33%
13. Colorectal Neoplasms 28%
14. Meta-Analysis 28%
15. Skin 27%
16. Optical Coherence Tomography 26%
17. Survival 26%
18. Blood Donors 26%
19. Macular Degeneration 24%
20. Pain 23%
21. Breast Neoplasms 22%
22. Placebos 22%
23. Incidence 21%
24. Recurrence 20%
25. Polycythemia Vera 20%
26. Primary Myelofibrosis 20%
27. ST Elevation Myocardial Infarction 20%
28. Databases 19%
29. Biomarkers 18%
30. Cross-Sectional Studies 17%
31. Child 17%
32. Coronavirus 17%
33. Emergencies 17%
34. Pregnancy 17%
35. Observational Studies 17%
36. Prospective Studies 17%
37. Infections 17%
38. Guidelines 16%
39. Endocarditis 16%
40. Comorbidity 16%
41. Odds Ratio 16%
42. Patient Reported Outcome Measures 16%
43. Colonic Neoplasms 15%
44. Multicenter Studies 15%
45. Exercise 15%
46. Inflammation 15%
47. Chronic Obstructive Pulmonary Disease 15%
48. Electroencephalography 14%
49. Intensive Care Units 14%
50. Health 14%
51. Genes 14%
52. Dermatology 14%
53. Percutaneous Coronary Intervention 14%
54. Mutation 13%
55. Essential Thrombocythemia 13%
56. HLA Antigens 13%
57. Psoriasis 13%
58. Magnetic Resonance Imaging 13%
59. Myocardial Infarction 13%
60. Radiotherapy 12%
61. Rheumatoid Arthritis 12%
62. Delivery of Health Care 12%
63. Skin Diseases 12%
64. Skin Neoplasms 12%
65. Microscopic Colitis 12%
66. Stroke 11%
67. Retrospective Studies 11%
68. Alzheimer Disease 11%
69. Biopsy 11%
70. Kidney 11%
71. Herniorrhaphy 11%
72. Actinic Keratosis 11%
73. Depression 11%
74. Interferons 11%
75. Colorectal Surgery 10%
76. Nerve Block 10%
77. Arthroplasty 10%
78. Heart Failure 10%
79. Dialysis 10%
80. Anti-Bacterial Agents 10%
81. Hip 10%
82. Neoplasm Metastasis 10%
83. Inflammatory Bowel Diseases 10%
84. SARS Virus 9%
85. Safety 9%
86. Clinical Trials 9%
87. Nurses 9%
88. Atrial Fibrillation 9%
89. Irritable Bowel Syndrome 9%
90. Morbidity 9%
91. Postoperative Pain 9%
92. Rectal Neoplasms 9%
93. Adalimumab 9%
94. Pandemics 9%
95. Seizures 9%
96. Wounds and Injuries 9%
97. Lung 9%
98. Anxiety 9%
99. Smoking 9%
100. Education 8%